Morgan Sheng
Corporate Officer/Principal presso Massachusetts Institute of Technology
Posizioni attive di Morgan Sheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Massachusetts Institute of Technology | Corporate Officer/Principal | - | - |
Storia della carriera di Morgan Sheng
Precedenti posizioni note di Morgan Sheng
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PREVAIL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 15/11/2019 | 22/01/2021 |
| Independent Dir/Board Member | 15/11/2019 | 22/01/2021 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 15/09/2008 | - |
Formazione di Morgan Sheng
| University of Oxford | Undergraduate Degree |
| University of London | Doctorate Degree |
| Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Morgan Sheng
- Esperienza
